Martha J. Carter, Chief Regulatory Officer at ALBIREO PHARMA, INC. (ALBO), sold 40,000 shares at $39.82 ($1.7M) on 2020-09-09, disclosed to the SEC on 2020-09-10.
Open-market sale of $1.7M ALBO by Chief Regulatory Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.55 | 10,000 | $456K | 26.9% |
| 2 | $38.68 | 7,500 | $290K | 17.1% |
| 3 | $39.82 | 2,500 | $100K | 5.9% |
| 4 | $42.41 | 10,000 | $424K | 25.0% |
| 5 | $42.41 | 10,000 | $424K | 25.0% |
| Total | $42.33 avg | 40,000 |
| $1.7M |
| 100% |
| Filing → |
| ALBO | SELL | 2022-10-25 | $2K | — | Filing → |
| ALBO | SELL | 2022-07-25 | $3K | — | Filing → |
| ALBO | SELL | 2022-04-25 | $3K | — | Filing → |